Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… ELOCON (mometasone furoate) Cream, 0.1%, Schering NDA 19-625/S-012 & S-013 7/17/02 7/24/02 7/19/02 | ELOCON (mometasone furoate) Lotion, 0.1%, Schering NDA 19-796/S-08 & S-015 7/17/02 7/24/02 7/19/02 | ELOCON (mometasone furoate) Ointment, 0.1%, Schering NDA 19-543/S-014 12/15/02 1/23/03 12/16/02 | ELOCON (mometasone furoate) Ointment, 0.1%, Schering NDA 19-543/S-011 & S-013 Mometasone Furoate Cream USP, 0.1%, Altana ANDA 76-171 7/10/02 | Mometasone Furoate Ointment USP, 0.1%, Clay-Park Labs, ANDA 76-067 3/18/02 4/10/03 | Mometasone Furoate Ointment USP, 0.1%, Clay-Park Labs, ANDA 76-067 2/1/02 | Mometasone Furoate Topical Solution USP, 0.1%, Altana ANDA 75-919 Nasonex (Mometasone Furoate Monohydrate) Aqueous Nasal Spray, Schering Corp. NDA 20-762/S-014 3/3/03 3/10/03 Nasonex Nasal Spray, 50 mcg., Schering Corp. NDA 20-762/S-001 11/19/98 1/12/99 5/25/01 | Nasonex Indication: Prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and the treatment of the nasal symptoms of perennial allergic rhinitis, in adults and children 12 years of age and older. Mometasone Furoate Ointment USP, Atrix Mometasone Furoate Topical Solution, Atrix Laboratories, Nasonex (Mometasone Furoate Monohydrate) Aqueous Nasal Spray, Schering Corp. Mometasone Furoate Cream USP, Atrix Laboratories, Inc., Nasonex (mometasone furoate monohydrate) Aqueous Nasal Spray, Schering Corp., Formulation Revision | Mometasone Furoate Cream, Taro Pharmaceuticals, Tentative Approval |Mometasone Furoate Ointment, Taro Pharmaceuticals, Approval | Mometasone Furoate Topical Solution, Taro Pharmaceuticals, Tentative Approval | Mometasone Furoate Ointment, Altana Inc., Approval 077061 | Asmanex Twisthaler (mometasone furoate) inhalation powder, Schering Corp., Approval | Mometasone Furate Topical Solution, Agis, Approval | Mometasone Furoate Cream, Altana Inc., Approval | ELOCON (mometasone furoate) Lotion, Schering Corp., Labeling Revision | Mometasone Furoate Cream, G & W Labs, Tentative Approval | Mometasone Furoate Lotion, G & W Labs, Tentative Approval| Mometasone Furoate Topical Solution USP, Taro Pharma, Approval | Mometasone Furoate Cream, G&W Labs, Approval | Mometasone Furoate Ointment, G & W Labs, Approval | Mometasone Furoate Cream, Tolmar Inc., Approval | Mometasone Furoate Topical Solution, Tolmar Inc., Approval | Mometasone Furoate Topical Solution, G&W Labs, Approval | Mometasone Furoate Topical Solution, Altana Inc., Approval | Mometasone Furoate Cream, Glenmark Generics, Inc., USA, Approval | Mometasone Furoate Ointment, Glenmark Generics, Inc., USA, Approval | Nasonex (mometasone furoate) Nasal Spray, Schering-Plough, Efficacy Supplement with Clinical Data to Support | Dulera (mometasone furoate and formoterol fumarate) Inhalation Aerosol, Schering Corp., Approval | Asmanex Twisthaler (mometasone furoate) Inhalation Powder, Schering-Plough Corporation, Approval | Nasonex (mometasone furoate monohydrate) Nasal Spray, Schering Plough, Efficacy Supplement with Clinical Data to Support | Dulera (mometasone furoate and formoterol fumarate) Inhalation Aerosol, Schering-Plough Corp., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com